Monday, November 4, 2019

40-year-old woman with melanoma of the right knee

A teaching case from MD Anderson Cancer Center
Behrang Amini

40-year-old woman with right knee melanoma
Wide local excision 6 years ago with negative sentinel lymph node biopsy
Liver and mesenteric mets 1 year ago
Started therapy with dabrafenib and trametinib 2 months ago
Most recent PET was negative




Presents with FDG PET/CT below: 
 

Note multiple sites of new uptake in the lower limbs, more numerous on the left (primary was in the right knee)

Axial fused PET/CT shows subcutaneous location of lesions




Axial CT image shows uptake localizing to subtle increased attenuation


Initial instinct is to call this metastatic disease and change therapy.

This is BRAF inhibitor-induced paniculitis.

Currently three BRAF inhibitors are approved in Europe and US for the treatment of patients with BRAF-mutant advanced melanoma: 
Vemurafenib
Dabrafenib
Encorafenib
unknown_3.pdf
unknown_2.pdf

No comments:

Post a Comment

OCAD LIVE 2020 Registration is Now Open

Join us for OCAD Live 2020! Saturday, March 28th 10 am - 5 pm UCLA - Santa Monica Orthopaedic Hospital Click HERE to register